Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Alternus Clean Energy Inc. (ALCE)

Alternus Clean Energy Inc. (ALCE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0590 +0.0190 (+47.50%) 03/13/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0590 unch (unch) 15:56 ET
News & Headlines for Thu, Mar 13th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Alternus Clean Energy to Participate at The Microcap Conference 2025 Alongside Top Growth Companies

New York, New York--(Newsfile Corp. - January 27, 2025) - Alternus Clean Energy, Inc. (NASDAQ: ALCE) ("Alternus"), a global provider of international renewable energy solutions, today announced that it...

ALCE : 0.0590 (+47.50%)
ACLEW : 0.0025 (+4.17%)
Alternus Clean Energy Announces Closing of $2.25 Million Private Placement

New York, New York--(Newsfile Corp. - January 24, 2025) - Alternus Clean Energy, Inc. (NASDAQ: ALCE) ("ALCE", "Alternus" or the "Company") a renewable energy company, today announced the closing of its...

ALCE : 0.0590 (+47.50%)
ACLEW : 0.0025 (+4.17%)
Alternus Clean Energy Announces Pricing of $2.25 Million Private Placement

New York, New York--(Newsfile Corp. - January 22, 2025) - Alternus Clean Energy, Inc. (NASDAQ: ALCE) ("ALCE", "Alternus" or the "Company") a renewable energy company, today announced the pricing of an...

ALCE : 0.0590 (+47.50%)
ACLEW : 0.0025 (+4.17%)
Alternus Clean Energy CEO Vincent Browne Highlights Milestones and Growth Vision for 2025 on Proactiveinvestors.com

New York, New York--(Newsfile Corp. - January 16, 2025) - Alternus Clean Energy, Inc. (NASDAQ: ALCE) ("Alternus"), a global provider of international renewable energy solutions, today announced that Vincent...

ALCE : 0.0590 (+47.50%)
ACLEW : 0.0025 (+4.17%)
Alternus Clean Energy Secures Full Permitting for First of Its Eleven Italian Solar Projects; Construction is Expected to Start in Q2 2025

Upon completion, the 18MW project is expected to generate approximately $2 million annually in recurring revenues.New York, New York--(Newsfile Corp. - January 8, 2025) - Alternus Clean Energy, Inc. (NASDAQ:...

ALCE : 0.0590 (+47.50%)
ACLEW : 0.0025 (+4.17%)
Alternus Clean Energy Completes Acquisition of LiiON, a Leading US-Based Provider of Advanced Energy Storage Solutions

LiiON brings major clients like Amazon, Walmart, and NASACompleted acquisition is a significant step in Alternus' transition to become a more comprehensive clean energy providerNew York, New York--(Newsfile...

ALCE : 0.0590 (+47.50%)
ACLEW : 0.0025 (+4.17%)
Alternus Clean Energy Announces Binding Terms for Acquisition of Leading Storage and Solution Provider LiiON, LLC

Acquisition will bring proven pedigree and expertise in battery storage and support push into MicrogridsNew York, New York--(Newsfile Corp. - November 25, 2024) - Alternus Clean Energy, Inc. (NASDAQ: ALCE)...

ALCE : 0.0590 (+47.50%)
ACLEW : 0.0025 (+4.17%)
Alternus Clean Energy Continues Deleveraging Program by Removing Additional $30 Million of Debt, Improving Shareholder Equity by Approximately $4 Million

New York, New York--(Newsfile Corp. - November 12, 2024) - Alternus Clean Energy, Inc. (NASDAQ: ALCE) ("ALCE", "Company") announces that it recently completed the sale of certain of its SPVs to Alternus...

ALCE : 0.0590 (+47.50%)
ACLEW : 0.0025 (+4.17%)
Alternus Secures First Investment Tax Credit under the IRA to Finance Solar Projects

Net funds from tax credit transfer reduced existing debt, further deleveraging balance sheet.Fort Mill, South Carolina--(Newsfile Corp. - October 23, 2024) - Alternus Clean Energy, Inc. (NASDAQ: ALCE)...

ALCE : 0.0590 (+47.50%)
ACLEW : 0.0025 (+4.17%)
Alternus Clean Energy, Inc. Announces 1-for-25 Reverse Stock Split as Part of Nasdaq Compliance Plan

Fort Mill, South Carolina--(Newsfile Corp. - October 9, 2024) - Alternus Clean Energy Inc. (NASDAQ: ALCE) ("Alternus"), a leading utility-scale transatlantic, clean energy independent power producer (IPP),...

ALCE : 0.0590 (+47.50%)
ACLEW : 0.0025 (+4.17%)

Barchart Exclusives

Is Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?
Amgen is hoping to rival Novo Nordisk and Eli Lilly in the weight-loss drug market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals